[Effect of single-using or combined-using lamivudine/interferon-alpha 1b on serum markers in patients with hepatitis B].
Yan
Jing
J
Department of Infectious Diseases of Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China.
Zhang
Li Sha
LS
Zhao
Xue Ke
XK
D000293:Adolescent; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004279:DNA, Viral / Q000097:blood; D004359:Drug Therapy, Combination; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000188:drug therapy*; D006512:Hepatitis B Core Antigens / Q000097:blood; D006513:Hepatitis B e Antigens / Q000097:blood; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D019259:Lamivudine / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
D000998:Antiviral Agents; D004279:DNA, Viral; D006512:Hepatitis B Core Antigens; D006513:Hepatitis B e Antigens; D016898:Interferon-alpha; D019259:Lamivudine